Predict your next investment

Corporation
HEALTHCARE | Drug Manufacturing / Generics
bright-gene.com

See what CB Insights has to offer

Founded Year

2001

Stage

IPO | IPO

Total Raised

$80.28M

Date of IPO

11/8/2019

About BrightGene Bio-Medical Technology

BrightGene Bio-Medical Technology is a biopharmaceutical company that engages in the research, development, and manufacturing of high-value generics, such as complex Active Pharmaceutical Ingredients (API) and Intermediates.

BrightGene Bio-Medical Technology Headquarter Location

Building C25-C31, No. 218 Xinghu Road Suzhou Industrial Park

Suzhou, Jiangsu, 215123,

China

+86 0512-62620988

Latest BrightGene Bio-Medical Technology News

Remdesivir Market Study, Future Prospects ,Covid 19 Impact Analysis, Growth Forecast 2028 || Top Players Gilead Sciences, BrightGene Bio-Medical Technology, Saptagir Laboratories

Mar 1, 2021

|| Top Players Gilead Sciences, BrightGene Bio-Medical Technology, Saptagir Laboratories The Report Titled on “Remdesivir Market Report- Development Trends, Size, Share, Demand, Growth, Industry Analysis & Opportunity Assessment in 2021” firstly introduced the Remdesivir Industry.This report gives you so valuable and essentials data of Market size, share, trends, Growth, applications, forecast and cost analysis.The report takes into account the impact of the COVID-19 pandemic on the Remdesivir market and is perfect for precision and accuracy that will help to meet business requirements at affordable rates. It will help you to grow in the international Market. The study breaks market by key regions that includes North America, Europe, Asia-Pacific with country level break-up and provide volume and value related cross segmented information by each country. Remdesivir market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 9,925.61 million by 2028 and will grow at a CAGR of 27.46% in the above mentioned forecast period. Get Free Sample PDF Copy (Including FULL TOC, Graphs And Tables) Of This Report @  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-remdesivir-market Remdesivir Market Scenario The remdesivir market is majorly driven by the rapidly increasing need for a drug that can be used for the treatment of patient with severe COVID-19 symptoms. In addition, the high occurrences of pandemics like COVID-19, Ebola, along with the increasing prevalence of  viral diseases  are also contributing to rising in the global market. Also the Remdesivir (RDV) is one of the promising drugs which are currently being used for the treatment of the COVID19 disease and is the key factor affecting remdesivir market trends over the forecast period of 2021 to 2028. Global Remdesivir Market will rise from Covid-19 crisis at moderate growth rate during 2021 to 2028. Remdesivir market includes comprehensive information derived from depth study on Industry historical and forecast market data. Global Market Size to expand moderately as the new developments and Impact of COVID19 over the forecast period. Additionally, the rising focus on making remdesivir both available and affordable to governments and patients around the globe is also responsible for the development of remdesivir market over the forecast period. Furthermore, the remdesivir is being tested in multiple phase 3 clinical trials as a treatment for reasonably and severely ill COVID-19 patients and is also exceedingly influencing the demand and growth of the remdesivir market. Key Players Studied In The Global Remdesivir Market: Gilead Sciences, Inc Global Remdesivir Market Scope And Market Size On the basis of dosage, the remdesivir market is segmented into 2.5mg, 5mg, 100mg and 200mg. Based on patient type, the remdesivir market is segmented into adult, pediatric and geriatric. On the basis of form, the remdesivir market is segmented into lyophilized powder and concentrated solution. Based on application, the remdesivir market is segmented into ebola, SARS-COV, MERS-COV and COVID-19. COVID-19 has further been segmented into invasive mechanical ventilation and non-Invasive mechanical ventilation. The end users segment of the remdesivir market is segmented into hospitals, clinics, pharmacy and drug stores and online pharmacies. Remdesivir Market explains the key macro-economic factors that are expected to influence the growth of the market over the forecast period. The report also highlights macroeconomic factors and major forecast factors that will shape market growth, the reimbursement scenario, regulatory scenario, and the value chain analysis. Besides, it provides key dynamics of the Remdesivir market, which include the drivers, restraints, and opportunity analysis. The report also focuses on the market analysis of competitors based on revenue, single point view of portfolio across industry segments, and their relative market position. The opportunity analysis for the agents will help readers understand the market opportunities, based on which they can plan their strategies. Complete Guidance Of The Global Remdesivir Market Report: The Remdesivir market report offers the most infallible and accurate data through the 360 degree research methodology. While formulating Remdesivir market research report, research analyst give 24×7 support to precisely understand the business requirements. With the help of SWOT analysis provided in the market research report, accurate intelligence can be obtained that aid business identify opportunities as well as both internal and external influences. To comprehend Global Remdesivir Market dynamics in the world mainly, the worldwide market is analyzed across major global regions. Data Bridge Market Research also provides customized specific regional and country-level reports for the following areas. Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report. Segmentation Analysis: By Dosage (2.5MG, 5MG, 100MG, 200MG) By Patient Type (Adult, Pediatric, Geriatric) By Form (Lyophilized Powder, Concentrated Solution) By Application (Ebola, SARS-COV, MERS-COV, COVID-19) By End User (Hospitals, Clinics, Pharmacy and Drug Stores, Online Pharmacies) Remdesivir market research reports takes much of the guesswork out of the process, which saves huge amount of time. The report can also be used to research best practices, prepare RFPs, get ready for client meetings, and create content. The report provides insights into questions and helps validate information. Remdesivir Market: Regional Analysis Includes: North America ( U.S., Canada and Mexico),Germany, France, U.K., Netherlands, Switzerland Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC),Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India. Rest of Middle East and Africa (MEA) Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia Middle East and Africa (MEA), Philippines, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Argentina and Rest of South America Key Market Players: Global Remdesivir Market: The major players covered in the remdesivir market report are Gilead Sciences, Inc., BrightGene Bio-Medical Technology Co., Ltd., Saptagir Laboratories Pvt. Ltd., Ferozsons Laboratories Limited, Mylan N.V., Hovione, Syngene, EVA PHARM, Zydus Cadila., Pfizer Inc., Dr. Reddy’s Laboratories Ltd., Biocon, Hikma Pharmaceuticals PLC, Beximco Pharmaceuticals Ltd., Hunan Warrant Chiral Pharmaceutical Co., Ltd., Hetero, Everest Organics Limited, PI & PI BOITECH INC, Cipla Inc., and Jubilant Life Sciences Limited among other domestic and global players. Any Query? Enquire Here For Discount Or Report Customization:  https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-remdesivir-market Request A Customized Copy Of Remdesivir Report The Remdesivir market report also covers, the trade scenario, Porter’s Analysis, Industry analysis, value chain analysis, company market share, segmental analysis. Points Covered In Table Of Content Of Global Remdesivir Market : Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the market Chapter 2: Exclusive Summary – the basic information of the Remdesivir Market. Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Remdesivir Chapter 4: Presenting the Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis. Chapter 5: Displaying market size by Type, End User and Region Chapter 6: Evaluating the leading manufacturers of the market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries (2021-2028). Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source Continued………… Finally, Remdesivir Market is a valuable source of guidance for individuals and companies in decision framework. Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia. To Understand How Covid-19 Impact Is Covered In This Report, Get Free Covid-19 Sample@  https://www.databridgemarketresearch.com/covid-19-impact/global-remdesivir-market  About Data Bridge Market Research: Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.” We provide a variety of services such as market verified industry reports, technology trend analysis, Formative market research, strategic consulting, vendor analysis, production and demand analysis, consumer impact studies among many others. Contact Us:-            UK: +44 208 089 1725 Hong Kong: +852 8192 7475

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing BrightGene Bio-Medical Technology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BrightGene Bio-Medical Technology is included in 2 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

S

Sequoia Capital China Investments 2018-2019

149 items

BrightGene Bio-Medical Technology Patents

BrightGene Bio-Medical Technology has filed 13 patents.

The 3 most popular patent topics include:

  • Experimental cancer drugs
  • Transcription factors
  • Polymers
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/6/2019

2/9/2021

Experimental cancer drugs, Stereochemistry, Piperazines, Amines, Transcription factors

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

12/6/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

2/9/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Experimental cancer drugs, Stereochemistry, Piperazines, Amines, Transcription factors

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

BrightGene Bio-Medical Technology Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

BrightGene Bio-Medical Technology Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.